Log in
Enquire now
Treos Bio

Treos Bio

Treos Bio is a next-generation off-the-shelf peptide cancer immunotherapies developer founded in 2013 by John Hautman.

OverviewStructured DataIssuesContributors

Contents

treosbio.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Engineering
Engineering
Healthcare
Healthcare
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Genetics
Genetics
Vaccine
Vaccine
...
Location
United Kingdom
United Kingdom
London
London
0
B2X
B2B
B2B
CEO
Christopher Gallen
Christopher Gallen
0
Founder
‌
John Hautman
Pitchbook URL
pitchbook.com/profiles...170517-97
Legal Name
Treos Bio, Inc.
Legal classification
Corporation
Corporation
Number of Employees (Ranges)
11 – 50
Email Address
info@treosbio.com0
mlevitan@soleburytrout.com0
zlockshin@soleburytrout.com0
Phone Number
+164637829600
+4420314173700
Full Address
The Harley Building 79 New Cavendish Street London W1W 6XB United Kingdom0
Investors
BXR Partners LLP
BXR Partners LLP
Founded Date
2013
Total Funding Amount (USD)
10,100,000
Latest Funding Round Date
August 27, 2025
Business Model
Commerce
CFO
‌
Gabor Illes
Latest Funding Type
‌
Venture round
Patents Assigned (Count)
1
Country
United Kingdom
United Kingdom
0
Headquarters
London
London

Other attributes

Latest Funding Round Amount (USD)
2,100,000

Treos Bio is a clinical stage company introducing a disruptive computational technology to change the paradigm of cancer immunotherapy development by by resolving the dual challenges of patient and tumor heterogeneity.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Treos Bio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.